30/06/2022 - 14:47

Chimeric and US university ink new deal on cancer treatment

30/06/2022 - 14:47

Bookmark

Save articles for future reference.

Biotech company Chimeric Therapeutics has advanced its cutting-edge cancer-fighting work by expanding a licencing agreement with a top US university for breakthrough cancer treatment. The clinical-stage cell therapy company hopes the new agreement, through acquisition of critical know-how, will expedite its ambition to commercialise the treatment. Chimeric plans to use the treatment in a clinical study of patients with gastrointestinal cancers.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options